Amgen Inc. raises 2025 revenue guidance on strong Repatha and Imdelltra sales and dividend hike. Click for this AMGN update.

Researchers have shown that glioblastoma can take over the skull marrow to dissolve bone and feed its own growth, suggesting ...

This Review chronicles the events that led to an increased understanding of osteoclast biology, the identification of osteoprotegerin (OPG) and the signalling pathway mediated by receptor activator of ...

In 2026, J&J expects accelerated growth in the Innovative Medicine segment to be driven by its key products as well as new ...

Type 2 diabetes is a recognized risk factor for vertebral fractures, which can lead to long-term disability and increased ...

GLP-1 receptor agonists were linked to a small long-term reduction in vertebral fractures in a cohort study. The retrospective study was based on electronic health records of people with type 2 ...

In another first, Sandoz launched in November 2025 the first FDA-approved biosimilar of Tysabri (natalizumab). Tyruko (natalizumab-sztn) is used to treat adult patients with relapsing multiple ...

Beyond their established cardiometabolic benefits, GLP-1 receptor agonists also may be tied to improved bone health, based on an observational report. Adults with type 2 diabetes on GLP-1 agonists ...

Explore the latest advancements in denosumab biosimilars, enhancing treatment options for osteoporosis and bone metastases in ...

1 MRC Centre for Immune Regulation, Institute for Biomedical Research, College of Medical and Dental Sciences, University of Birmingham, Birmingham, UK Objectives In rheumatoid arthritis (RA), a ...

Abstract: In this study, the first to investigate the potential of using extremely low-frequency electric fields (ELFEFs) to improve osteoporosis, we examined the effects of ELFEF exposure on bone ...